Einstein Receives $4 Million to Test HPV Microbicide
Albert Einstein College of MedicineThe National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard® against the human papillomavirus (HPV), which causes cervical cancer. The research will evaluate the efficacy of Carraguard®, – a clear gel made from the seaweed derivative carrageenan – in preventing new HPV infections in women.